PATENT CLAIM ANALYSIS

Application Number: 15756342
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "295000"]

Abstract:
Provided are a conjugate of memantine and arctigenin, and a pharmaceutical composition comprising the conjugate. The conjugate can treat diseases associated with Aβ or Tau protein pathways, such as Alzheimer's disease or Parkinson's disease.

Claim (Index 9):
The method according to  claim 8 , wherein the disease is a neurodegenerative disease, particularly Alzheimer's disease or Parkinson's disease.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13063525', '16084979', '13940016', '15552556', '13442244']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7593273388501351
- 35 USC 102 Novelty (BERT): 0.4976626591280961
- Combined Prediction Score: 0.7331608708779312
- Mean Citation Score: 207.164244
- Max Citation Score: 211.74594
- Similarity Product: 142.96348493030547

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test